Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

Menú

Buscar estudios clínicos de BMS
Ícono de BMS, studio Reclutando

Recruiting

ID del estudio CV029-1024  |   NCT07226817

A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

Resumen

  • Phase 1
  • Ícono de género masculino y femenino
  • 18-60
  • 1
  • Ícono de BMS, studio Reclutando
    Recruiting

Descripción general

This study is designed to evaluate the relative bioavailability (rBA) of multiple test tablet formulations of BMS-986435 compared to an equal dose of the BMS-986435 reference tablet formulation. The effect of food on the selected BMS-986435 tablet formulation will also be evaluated.

Imprimir Imprimir
Email Correo electrónico

Centro de reclutamiento más cercano

Criterios clave de elegibilidad

Inclusion Criteria - Participants must have a body weight of ≥ 45 kg and BMI between 18 and 32 kg/m2, inclusive - Participants must be healthy as determined by medical history, physical examination, vital signs, 12-lead electrocardiogram (ECG), clinical laboratory assessments - Participants must have documented left ventricular ejection fraction (LVEF) ≥ 60% and absence of significant cardiac abnormality at screening, as determined by local transthoracic echocardiogram (TTE) assessment - Other protocol-defined Inclusion/Exclusion criteria apply

Opciones de tratamiento

Brazos del estudio

INTERVENCIÓN ASIGNADA

Brazos del estudio

Experimental: Treatment A

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment B

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment C

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment D

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment E

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment F

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435

Brazos del estudio

Experimental: Treatment G

INTERVENCIÓN ASIGNADA
  • Drug: BMS-986435
Dé el primer paso para ver si es compatible con un estudio clínico - Verifique su elegibilidad
Verifique su elegibilidad
Responda algunas preguntas sobre su salud para ver si puede ser compatible con este enstudio.
Compatibilizar con un estudio
Si es compatible, haga clic en el estudio para ver la lista de ubicaciones de los centros del estudio.
Seleccione una ubicación del centro del estudio
Seleccione una ubicación del centro del estudio que sea conveniente para usted
Registrarse
Proporcione sus datos de contacto para que el centro del estudio se comunique con usted.

Ayúdenos a mejorar su experiencia en el sitio web. Comparta sus comentarios con nuestro equipo en BMS Clinical Trials para mejorar su experiencia y la de los demás. Gracias